On Oct. 12, the Department of Medicine and the Cancer Center announced the appointment of David Ryan, MD, as the new chief of Hematology/Oncology at the MGH. Ryan, who succeeds Jose Baselga, MD, PhD, joined the MGH Cancer Center in 1998. He has served as associate chief of Hematology/Oncology and clinical director of the MGH Cancer Center since 2009.
“We are delighted to have Dr. Ryan in this new role,” says Daniel Haber, MD, PhD, director of the Cancer Center. “His clinical vision, together with his skill, enthusiasm and commitment, will ensure this division continues to flourish.”
Ryan, clinical director of the MGH Tucker Gosnell Center for Gastrointestinal Malignances since 2003, is an authority on the treatment of gastrointestinal cancers as well as the design and conduct of clinical trials for patients with those cancers. His expertise has been recognized by membership in leading national committees, including clinical task forces for the National Cancer Institute and the National Comprehensive Cancer Center Network. He currently co-chairs the Partners Colon Cancer Care Redesign Team for the MGH.
Read more articles from the 10/19/12 Hotline issue.